SAIC's AML rules leave questions

June 17, 2009 | BY

clpstaff &clp articles &

Lawyers in China have generally welcomed two new sets of procedural rules to implement the Anti-Monopoly Law (AML), though they say there are important…

Lawyers in China have generally welcomed two new sets of procedural rules to implement the Anti-Monopoly Law (AML), though they say there are important issues that still need to be addressed.

On June 5, the State Administration of Industry and Commerce (SAIC) published one set of rules dealing with procedures for the investigation and handling of cases involving monopoly agreements and abuses of a dominant market position. The other specified procedures for investigation and handling of administrative monopolies.

Legal commentators suggest that promulgation of these new rules, which will take effect on July 1, may herald the start of AML enforcement by SAIC (which to-date has not taken any formal or public actions under the AML despite rumours of many complaints).

Allen & Overy's Beijing-based pan-Asian antitrust head François Renard said the new rules were a good start, but that there were still important gaps. “There are issues that should have been addressed,” he said. “For example, there are not enough rules protecting confidentiality and there are no rules protecting legally privileged documents that should not be reviewed by the authority.”

The rules tackling abuse of administrative power are strongly geared towards the provincial level and the blocking of imports from one province to another. But with the rules addressing monopoly agreements and abuse of a dominant position, SAIC seems to be centralising its power.

Unlike in earlier drafts of the rules – which gave blanket authorisation to Provincial Administrations of Industry and Commerce (Provincial AICs) – the new rules provide for delegation to Provincial AICs only in certain circumstances and always under the supervision of SAIC.

“Influential, major cases should be reviewed by SAIC while other cases would be dealt with at provincial level,” said Renard. “But there is now a centralised approach that will ensure some sort of supervision, which is very positive.”

While Articles 3 and 9 of the rules addressing monopoly agreements and abuse of a dominant position focus on the allocation of power between SAIC and the provinces, Articles 5-7 focus on investigations and reporting.

Requirements made of those who submit complaints of suspected AML violations include making the complaint in writing, signing it, and providing information about themselves, the suspected violator, relevant facts and relevant evidence.

Renard said the burdensome nature of these requirements should avoid frivolous complaints. “Some people in China have no problem complaining to authorities – even on unfounded grounds.”

The rules provide a wide range of methods for SAIC or the Provincial AICs to investigate suspected anticompetitive conduct, “but there are not many details provided in the rules, which leaves lots of questions on how they will actually be conducted,” said Renard. For example, the rules do not specify the evidentiary burden to be met before SAIC commences an investigation.

And some of the methods cited appear to be quite intrusive, perhaps indicating that AML investigations in China will have powers as extensive as those found in the US, Europe and elsewhere.

For example, Article 12b states that where the target under investigation is a business operator, it will be required to provide information on, among other things, overseas investment for the previous three years.

“I'm a bit sceptical over that,” said Renard. “Is [overseas investment] systematically related to antitrust matters? It is not clear why this very specific information would need to be requested in each proceeding.”

Article 12 goes on to state that 'the AIC and its officials hold a duty of confidentiality in respect of any commercial secrets they learn of during the course of their law-enforcement activities'.

“That's great but there's no specific obligation in the public version of the decision itself, which is normal practice in other jurisdictions,” said Renard. “And let's hope that any commercial secrets AIC learns are not widely circulated among the other authorities involved in investigations, because this clause only applies to AIC and officials which is worrisome.”

A final area of concern is over the proposed leniency programme for parties that voluntarily report on and provide evidence of monopoly agreements. While the leniency mechanism appears to be modeled after those in the US and EU, Renard noted one important difference.

Article 20 states that the relevant AIC may exempt from punishment entirely or adopt a lesser punishment for those that report on and provide evidence of monopoly agreements.

“The problem comes from one word, which also appears in the AML but which would have benefitted from some clarification,” said Renard. “The relevant AIC may exempt from punishment … If you are the first one you should receive immunity.”

He added: “I can see why they want to have discretion, but if a company that is willing to fully cooperate is not certain to get immunity what's their incentive to self-report? Why would they risk being fined based on information they voluntarily report? We need a common understanding of what they mean by 'may exempt from punishment'.”

While SAIC's procedural rules were contained in a document that ran over six pages, equivalent rules in the US, the EU and elsewhere typically run over some 50 pages. And although the rules do not come into effect until July 1, SAIC is reviewing several cases already.

Publication of SAIC's rules come as the Ministry of Commerce (Mofcom) announced that the AML may apply to Rio Tinto's proposed joint venture with BHP Billiton.

This premium content is reserved for
China Law & Practice Subscribers.

  • A database of over 3,000 essential documents including key PRC legislation translated into English
  • A choice of newsletters to alert you to changes affecting your business including sector specific updates
  • Premium access to the mobile optimized site for timely analysis that guides you through China's ever-changing business environment
For enterprise-wide or corporate enquiries, please contact our experienced Sales Professionals at +44 (0)203 868 7546 or [email protected]